The University of Chicago Header Logo

Connection

Harvey M. Golomb to Neoplasm Staging

Back to Details
This is a "connection" page, showing publications Harvey M. Golomb has written about Neoplasm Staging.
Harvey M. Golomb
Connection Strength
0.437
Neoplasm Staging
  1. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
    View in: PubMed
    Score: 0.057
  2. The staging of Hodgkin's disease. Hematol Oncol Clin North Am. 1989 Jun; 3(2):237-51.
    View in: PubMed
    Score: 0.055
  3. Perspective on staging approaches in the malignant lymphomas. Surg Gynecol Obstet. 1986 Aug; 163(2):193-201.
    View in: PubMed
    Score: 0.045
  4. Importance of substaging of stage III Hodgkin's disease. Semin Oncol. 1980 Jun; 7(2):136-43.
    View in: PubMed
    Score: 0.030
  5. Management of early-stage Hodgkin's disease: a continuing evolution. Semin Oncol. 1998 Aug; 25(4):476-82.
    View in: PubMed
    Score: 0.026
  6. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
    View in: PubMed
    Score: 0.017
  7. Role of systemic therapy in advanced non-small-cell lung cancer. Am J Med. 1990 Dec; 89(6):777-86.
    View in: PubMed
    Score: 0.015
  8. The staging of non-Hodgkin's lymphomas. Semin Oncol. 1990 Feb; 17(1):43-50.
    View in: PubMed
    Score: 0.014
  9. High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989 Jan 15; 63(2):238-42.
    View in: PubMed
    Score: 0.013
  10. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer. 1987 Jun 15; 59(12):2016-9.
    View in: PubMed
    Score: 0.012
  11. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. 1986 Oct; 100(4):621-8.
    View in: PubMed
    Score: 0.011
  12. Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease. Cancer. 1986 Feb 01; 57(3):471-6.
    View in: PubMed
    Score: 0.011
  13. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
    View in: PubMed
    Score: 0.010
  14. Diagnosis, staging, and treatment of the malignant lymphomas. Compr Ther. 1980 Jul; 6(7):48-56.
    View in: PubMed
    Score: 0.007
  15. The non-Hodgkin lymphomas. Curr Probl Cancer. 1980 Jan; 4(7):1-35.
    View in: PubMed
    Score: 0.007
  16. The role of gallium-67 scanning in the clinical staging and preoperative evaluation of patients with carcinoma of the lung. Ann Thorac Surg. 1979 Nov; 28(5):451-64.
    View in: PubMed
    Score: 0.007
  17. Lung cancer: A combined modality approach to staging and therapy. CA Cancer J Clin. 1979 Sep-Oct; 29(5):258-75.
    View in: PubMed
    Score: 0.007
  18. Small-cell carcinoma of the lung: the prognostic significance of stage on survival. Eur J Cancer (1965). 1979 Jun; 15(6):859-65.
    View in: PubMed
    Score: 0.007
  19. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
    View in: PubMed
    Score: 0.006
  20. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1978 Mar; 62(3):327-32.
    View in: PubMed
    Score: 0.006
  21. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol. 1997 Mar; 15(3):884-92.
    View in: PubMed
    Score: 0.006
  22. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
    View in: PubMed
    Score: 0.006
  23. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
    View in: PubMed
    Score: 0.005
  24. Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
    View in: PubMed
    Score: 0.004
  25. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
    View in: PubMed
    Score: 0.004
  26. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
    View in: PubMed
    Score: 0.004
  27. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
    View in: PubMed
    Score: 0.003
  28. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
    View in: PubMed
    Score: 0.003
  29. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer. Surgery. 1987 Oct; 102(4):652-9.
    View in: PubMed
    Score: 0.003
  30. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol. 1985 Dec; 3(12):1596-604.
    View in: PubMed
    Score: 0.003
  31. Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
    View in: PubMed
    Score: 0.003
  32. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct; 3(10):1309-17.
    View in: PubMed
    Score: 0.003
  33. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun; 3(6):758-68.
    View in: PubMed
    Score: 0.003
  34. The use of serum albumin for further classification of Stage III non-oat cell lung cancer and its therapeutic implications. Ann Thorac Surg. 1984 Feb; 37(2):115-22.
    View in: PubMed
    Score: 0.002
  35. Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
    View in: PubMed
    Score: 0.002
  36. VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
    View in: PubMed
    Score: 0.002
  37. Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study. Cancer Treat Rep. 1982 Apr; 66(4):733-41.
    View in: PubMed
    Score: 0.002
  38. Survival of patients with localized diffuse histiocytic lymphoma. Blood. 1981 Dec; 58(6):1218-23.
    View in: PubMed
    Score: 0.002
  39. Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9.
    View in: PubMed
    Score: 0.002
  40. Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. Ann Intern Med. 1980 Feb; 92(2 Pt 1):159-65.
    View in: PubMed
    Score: 0.002
  41. Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
    View in: PubMed
    Score: 0.002
  42. Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
    View in: PubMed
    Score: 0.002
  43. Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
    View in: PubMed
    Score: 0.002
  44. Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.